Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer

Fertility and Sterility

Volumn 86, Issue 3, 2006, Pages 588-596

  Mitwally, Mohamed F M ^a,b   Bhakoo, Helmata S ^a   Crickard, Kent ^a,c   Sullivan, Michael W ^a,c   Batt, Ronald E ^a   Yeh, John ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Infertility and IVF Associates   (United States)

Author keywords

Area under the curve; controlled ovarian hyperstimulation; estradiol; IVF ET

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN;

ADULT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED OVARY HYPERSTIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE SYNTHESIS; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; COHORT STUDIES; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; NEW YORK; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; STATISTICS; TREATMENT OUTCOME;

EID: 33748105995     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.02.086     Document Type: Article

References (54)

1. Leung C.K. Recent advances in clinical aspects of in vitro fertilization. Hong Kong Med J 6 (2000) 169-176
2. Jones Jr. H.W., Acosta A., Andrew M.C., Garcia J.E., Jones G.S., Mantzavinos T., et al. The importance of the follicular phase to success and failure in in-vitro fertilization. Fertil Steril 40 (1983) 317-321
3. Pittaway D.E., and Wentz S.C. Evaluation of the exponential rise of serum estradiol concentrations in human menopausal gonadotropin induced cycles. Fertil Steril 40 (1983) 763-767
4. 2 do things start to get fuzzy?. Fertil Steril 71 (1999) 584-586
5. Simón C., and Pellicer A. Low and high responders-at what levels of serum estradiol do things start to get fuzzy?. Fertil Steril 71 (1999) 583-584
6. Garcia J.E., Acosta A.A., Hsiu J.G., and Jones H.W. Advanced endometrial maturation after ovulation induction with human menopausal gonadotrophin/human chorionic gonadotrophin for in vitro fertilization. Fertil Steril 41 (1984) 31-37
7. 2 concentration on embryo implantation. Fertil Steril 49 (1988) 118-122
8. Testart J., Belaisch-Allart J., and Frydman R. Relationship between embryo transfer results and ovarian response and in vitro fertilization rates: analysis of 186 human pregnancies. Fertil Steril 45 (1986) 237-243
9. Pellicer A., Ruiz A., Castellví R.M., Calatayud C., Ruiz M., Tarín J.J., et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotropins?. Hum Reprod 4 (1989) 536-540
10. Paulson R.J., Sauer M.V., and Lobo R.A. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril 53 (1990) 870-874
11. Toner J.P., Brzyski R.G., Oehninger S., Veeck L.L., Simonetti S., and Muasher S.J. Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod 6 (1991) 284-289
12. Gelety T.J., and Buyalos R.P. The influence of supraphysiologic estradiol levels on human nidation. J Assist Reprod Genet 12 (1995) 406-412
13. Simon C., Cano F., Valbuena D., Remohi J., and Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 10 (1995) 2432-2437
14. Pellicer A., Valbueña D., Cano F., Remohí J., and Simón C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 65 (1996) 1190-1195
15. Bladford A.J., Najmabadi S., and Paulson R.J. Ultrastructural characteristics of the luteal phase endometrium in donors undergoing controlled ovarian hyperstimulation. Fertil Steril 67 (1997) 625-630
16. Simon C., Garcia Velasco J.J., Valbuena D., Peinado J.A., Moreno C., Remohi J., et al. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 70 (1998) 234-239
17. Ng E.H.Y., Yeung W.S., Lau E.Y.L., So W.W.K., and Ho P.C. High serum estradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 15 (2000) 250-255
18. 2 levels are not detrimental to clinical outcome if in vitro fertilization. Fertil Steril 54 (1990) 858-863
19. Tarín J.J., Sampaio M.C., Calatayud C., Castellvi R.M., Bonilla-Musoles F., and Pellicer A. Relativity of the concept "high responder to gonadotropins.". Hum Reprod 7 (1992) 19-22
20. 2 response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 67 (1997) 889-899
21. 2 levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril 72 (1999) 401-405
22. Levi L.J., Drews M.R., Bergh P.A., Miller B.T., and Scott R.T. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in-vitro fertilization cycles. Fertil Steril 76 (2001) 670-674
23. Pena J.E., Chang P.L., Chan LK Zeitoun K., Thornton M.H., and Sauer M.V. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. Hum Reprod 17 (2002) 83-87
24. Papageorgiou T., Guibert J., Goffinet F., Patrat C., Fulla Y., Janssens Y., et al. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod 17 (2002) 2846-2850
25. Blazar A.S., Hogan J.W., Frankfurter D., Hackett R., and Keefe D.L. Serum estradiol positively predicts outcomes in patients undergoing in vitro fertilization. Fertil Steril 81 (2004) 1707-1709
26. Mitwally M.F., and Casper R.F. Aromatase inhibitors in ovulation induction. Semin Reprod Med 22 (2004) 61-78
27. Tan S.L., Balen A., el Hussein E., Mills C., Campbell S., Yovich J., et al. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization. Fertil Steril 57 (1992) 1259-1264
28. Scott R.T., and Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 61 (1994) 880-885
29. Hendriks D.J., Klinkert E.R., Bancsi L.F., Looman C.W., Habbema J.D., te Velde E.R., et al. Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF). J Assist Reprod Genet 21 (2004) 65-72
30. 2 levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. Fertil Steril 69 (1998) 1015-1019
31. 2 concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertil Steril 74 (2000) 63-66
32. Kolb B.A., and Paulson R.J. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol 176 (1997) 1262-1267
33. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril 47 (1987) 895-909
34. Serhal P.F., and Craft I.L. Ovum donation-a simplified approach. Fertil Steril 48 (1987) 265-269
35. Devroey P., Camus M., van den Abbeel E., van Waesberghe L., Wisanto A., and van Steirteghem A.C. Establishment of 22 pregnancies after oocyte and embryo donation. Br J Obstet Gynaecol 96 (1989) 900-906
36. de Ziegler D., and Frydman R. Different implantation rates after transfers of cryopreserved embryos originating from donated oocytes or from regular in vitro fertilization. Fertil Steril 54 (1990) 682-688
37. Check J.H., Choe J.K., Katsoff D., Summers-Chase D., and Wilson C. Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer. J Assist Reprod Genet 16 (1999) 416-420
38. Check J.H., O'Shaughnessy A., Lurie D., Fisher C., and Adelson H.G. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme. Hum Reprod 10 (1995) 3022-3027
39. Saadat P., Boostanfar R., Slater C.C., Tourgeman D.E., Stanczyk F.Z., and Paulson R.J. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 82 (2004) 167-171
40. Valbuena D., Jasper M., Remohi J., Pellicer A., and Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod 14 (1999) 107-111
41. Damario M.A., Lesnick T.G., Lessey B.A., Kowalik A., Mandelin E., Seppala M., et al. Endometrial markers of uterine receptivity utilizing the donor oocyte model. Hum Reprod 16 (2001) 1893-1899
42. Tavaniotou A., Smitz J., Bourgain C., and Devroey P. Ovulation induction disrupts luteal phase function. Ann N Y Acad Sci 943 (2001) 55-63
43. Valbuena D., Martin J., de Pablo J.L., Remohi J., Pellicer A., and Simon C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 76 (2001) 962-968
44. Conaghan J., Dimitry E.S., Mills M., Margara R.A., and Winston R.M. Delayed human chorionic gonadotropin administration for in-vitro fertilisation. Lancet 1 (1989) 1323-1324
45. Dimitry E.S., and Oskarsson T. Conaghan J, Margara R, Winston RM. Beneficial effects of a 24 h delay in human chorionic gonadotrophin administration during in-vitro fertilization treatment cycles. Hum Reprod 6 (1991) 944-946
46. Clark L., Stanger J., and Brinsmead M. Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization. Fertil Steril 55 (1991) 1192-1194
47. Kolibianakis E.M., Albano C., Camus M., Tournaye H., Van Steirteghem A.C., and Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 82 (2004) 102-107
48. Mitwally M.F., Bhakoo H.S., Crickard K., Sullivan M.W., Batt R.E., and Yeh J. Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET. J Assist Reprod Genet 2 (2005) 57-63
49. Mitwally M.F., and Casper R.F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 77 (2002) 776-780
50. Mitwally M.F., and Casper R.F. Aromatase inhibition for ovarian stimulation: future avenues for infertility management. Curr Opin Obstet Gynecol 14 (2002) 255-263
51. Mitwally M.F., and Casper R.F. Aromatase inhibitors for the treatment of infertility. Expert Opin Investig Drugs 12 (2003) 353-371
52. Mitwally M.F., and Casper R.F. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 18 (2003) 1588-1597
53. de Ziegler D. The dawning of the noncancer uses of aromatase inhibitors in gynaecology. Hum Reprod 18 (2003) 1598-1602
54. de Ziegler D., Mattenberger C., Schwarz C., Ibecheole V., Fournet N., and Bianchi-Demicheli F. New tools for optimizing endometrial receptivity in controlled ovarian hyperstimulation: aromatase inhibitors and LH/(mini)hCG. Ann N Y Acad Sci 1034 (2004) 262-277